Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms and therapeutic strategies without systematic data synthesis
PubMed 32961264 · doi:10.1016/j.pharmthera.2020.107685
What was done
This is a narrative review outlining the biochemical mechanisms, physiological functions, and pathological actions of heme peroxidases (specifically myeloperoxidase, lactoperoxidase, peroxidasin, and thyroid peroxidase). The authors describe the oxidant species generated by these enzymes (e.g., HOCl, HOSCN, HOBr, HOI) and evaluate strategies for the therapeutic inhibition of specific peroxidase family members in inflammatory conditions.
What was found
The abstract provides a purely mechanistic and qualitative overview. No quantitative data, effect estimates, sample sizes, or numerical outcomes are reported.
Why it matters
Understanding the distinct oxidative chemistry and reaction kinetics of individual heme peroxidases helps guide the rational design of selective enzyme inhibitors to reduce inflammatory tissue injury without compromising essential physiological functions.
Limits
The abstract contains no empirical clinical or experimental data, systematic search criteria, or quantitative comparisons. As a narrative review, conclusions rely on mechanistic reasoning and qualitative summaries of existing literature.
Cited by
- supports Neutrophils release the enzyme myeloperoxidase (MPO), which produces hypochlorite (bleach) outside the cell, as well as proteases.